Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for amlodipine benzenesulfonate tablets
Announcement of Yiping Hong (300723.SZ): The company's wholly-owned subsidiary, Guangzhou Yiping Hong Pharmaceutical Co., Ltd., recently received a notification from the country...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the amlodipine besylate tablet. Indications for amlodipine besylate tablets include: hypertension and coronary artery disease (CAD).
Related Articles

HK Stock Market Move | JINHAI MED TECH (02225) rose more than 6% at the close of trading. The 8th China International Import Expo opens today. The company will release innovative technology for navigated spine endoscopy.

Domestic competition forces Starbucks Corporation (SBUX.US) to "let go" as Bo Yu Capital's $4 billion investment breaks the deadlock.

Break into the new track of "Predicting the Future"! Cryptocurrency exchange Gemini (GEMI.US) also wants to have a share.
HK Stock Market Move | JINHAI MED TECH (02225) rose more than 6% at the close of trading. The 8th China International Import Expo opens today. The company will release innovative technology for navigated spine endoscopy.

Domestic competition forces Starbucks Corporation (SBUX.US) to "let go" as Bo Yu Capital's $4 billion investment breaks the deadlock.

Break into the new track of "Predicting the Future"! Cryptocurrency exchange Gemini (GEMI.US) also wants to have a share.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


